This study investigates carbon ion radiotherapy for pancreatic cancer. The purpose of this study is to understand how this treatment works for people with this condition.
It evaluates the safety and effectiveness of combining carbon ion radiotherapy with other treatments for pancreatic cancer.
- Who can participate: Adults aged 18 to 80 with locally advanced or metastatic pancreatic adenocarcinoma can participate. Participants should have a confirmed diagnosis and meet specific health criteria.
- Study details: Participants will receive carbon ion radiotherapy combined with gemcitabine and nituzumab.